Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | December 15, 2011

Mammography’s Looming Dose War

By Greg Freiherr

As the dose wars in computed tomography (CT) draw to a close, a new one approaches, this one in mammography. The surprise should not be that this war is coming, but that it is taking so long to get here.

Mammography is the only imaging exam widely performed to screen apparently healthy people. It exposes them to ionizing radiation that, if administered in substantial quantities, can cause the very disease for which they are being screened. And it does so not once or twice, but annually for 30 or more years, per guidelines developed by the American Cancer Society (http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer), with the understanding that the risk of cancer from radiation exposure increases with cumulative dose.

Yet, in the past, when questions about the benefit of such repetitive screening were raised, they were immediately and soundly rebuked by women’s health leaders who defended screening as a major, if not the primary, reason for declining deaths due to breast cancer.  Then why now do I believe dose will become an issue? Because the technology to reduce dose is finally available in the United States  – and being aggressively marketed on its ability to significantly cut patient radiation dose.

This product – Philips’ Microdose mammography product – like so much about mammography and radiation dose, is steeped in irony. It is not new.  It has been sold for years in Europe. But Microdose entered the U.S. only this fall after Philips Healthcare acquired Sectra’s mammography modality business operations.

Three months after this deal was final, during the RSNA annual meeting in November, the ability of this product to cut patient radiation dose was ballyhooed on the exhibit floor of the McCormick Center, on television, even on the sides of buses ferrying radiologists to and from the meeting. The message was inescapable. And it will become so again in the year ahead.

Much like what happened in CT, all the vendors of mammography equipment will have to climb onboard this bandwagon and they will have to do so quickly. They cannot cede the high ground of digital mammography to newcomer Philips, nor can they risk appearing unsympathetic to concerns about radiation dose, when tens of millions of American women undergo mammography every year.

With this, we can expect a new vernacular for the modality, one reliant on the use of “low,” “optimized,” “minimum” and “efficient” as  descriptors of dose administered by mammography equipment. Vendors will use several, possibly all, these descriptors in the same paragraph, if not the same sentence to define their products.

When that happens, it will be a sure sign that this new war has begun.

Related Content

News | Oncology Diagnostics | July 27, 2016
July 27, 2016 — Cubresa Inc. announced the United States Patent and Trademark Office has issued a U.S.
UltraSPECT, Xpress3.Cardiac, nuclear imaging, RWJPE, New Jersey, Robert Wood Johnson Physician Enterprise
News | SPECT Imaging | July 25, 2016
UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-...
radiologists, radiation-related mortality risk, study, Amy Berrington de Gonzalez
News | Radiation Dose Management | July 22, 2016
Radiologists who graduated from medical school after 1940 do not face an increased risk of dying from radiation-related...
SonoCiné, 3-D multiplanar reconstruction software, Automated Whole Breast Ultrasound, AWBUS
Technology | Ultrasound Womens Healthcare | July 20, 2016
SonoCiné recently unveiled new 3-D whole breast multiplanar reconstruction software to improve early detection of...
Volpara Solutions, VolparaEnterprise software, breast imaging, performance
Technology | Breast Imaging | July 18, 2016
Volpara Solutions last week announced the commercial launch of VolparaEnterprise software, which helps breast imaging...
CT, computed tomography, radiation safety, best practices, pediatric patients
News | Computed Tomography (CT) | July 14, 2016
Alternative imaging procedures, radiation safety and parent education should be the top priorities when considering...
RamSoft, CT Dose Module, dose tracking and reporting, RSNA 2016, computed tomography
Technology | Radiation Dose Management | July 13, 2016
RamSoft recently announced integration with Scannerside radiation dose tracking software to introduce a new CT Dose...
breast density

As breast density increases, mammography sensitivity decreases and breast cancer risk elevates, highlighting the need for optimal approaches to individualized breast cancer screening.

Feature | Breast Density | July 06, 2016 | Rachel Brem, M.D.
As radiologists, most of us have seen firsthand how dense breast tissue can mask cancer in mammography. As breast...
women's health, radiation oncology

The Radiation Oncology Team of FUCAM.

Sponsored Content | Case Study | Women's Health | July 06, 2016
Following the global trend, cancer rates in Mexico continue to rise — and breast cancer is now the number-one killer of...
Navidea, Lymphoseek injection, breast cancer detction, scintigraphy, SNMMI 2016
News | Radiopharmaceuticals and Tracers | July 06, 2016
Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the Lymphoseek injection...
Overlay Init